Sonodynamic Therapy Complements PD-L1 Immune Checkpoint Inhibition in a Murine Model of Pancreatic Cancer

被引：0
|
作者：
Nesbitt, Heather [1 ]
Logan, Keiran [1 ]
Thomas, Keith [1 ]
Callan, Bridgeen [1 ]
Gao, Jinhui [1 ]
Mc Kaig, Thomas [1 ]
Taylor, Mark [2 ]
Love, Mark [3 ]
Stride, Eleanor [4 ]
Mc Hale, Anthony [1 ]
Callan, John [1 ]
机构：
[1] Ulster Univ, Coleraine, Londonderry, North Ireland
[2] Mater Hosp, Belfast, Antrim, North Ireland
[3] Royal Victoria Hosp, Belfast, Antrim, North Ireland
[4] Univ Oxford, Oxford, England
来源：
BRITISH JOURNAL OF SURGERY | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O-P04
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Quantifying PD-L1 Expression to Monitor Immune Checkpoint Therapy: Opportunities and Challenges
    Nimmagadda, Sridhar
    CANCERS, 2020, 12 (11) : 1 - 26
  • [32] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [33] Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immune-suppressive environment in pancreatic cancer
    Zhang, Yaqing
    Mathew, Esha
    Velez-Delgado, Ashley
    Long, Kristen B.
    Li, Dongjun
    Mendez, Flor M.
    Flannagan, Kevin
    Rhim, Andrew D.
    Simeone, Diane M.
    Beatty, Gregory L.
    di Magliano, Marina Pasca
    CANCER RESEARCH, 2016, 76
  • [34] Combinatorial Strategies With PD-1/PD-L1 Immune Checkpoint Blockade for Breast Cancer Therapy: Mechanisms and Clinical Outcomes
    Zheng, Dan
    Hou, Xiaolin
    Yu, Jing
    He, Xiujing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] PD-1/PD-L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)
    Tang, Quanying
    Zhao, Shikang
    Zhou, Ning
    He, Jinling
    Zu, Lingling
    Liu, Tingwen
    Song, Zuoqing
    Chen, Jun
    Peng, Ling
    Xu, Song
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 62 (04)
  • [36] Immune checkpoint therapy: From CTLA-4 to PD-1/PD-L1 and beyond
    Sharma, Padmanee
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Epigenetic regulation of PD-L1 expression and pancreatic cancer response to checkpoint immunotherapy
    Lu, Chunwan
    Liu, Kebin
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S652 - S654
  • [38] Regulation of Pulmonary Fibrosis by Immune Checkpoint PD-L1
    Geng, Y.
    Liang, C. J.
    Habiel, D. M.
    Coelho, A.
    Xie, T.
    Vrishika, K.
    Liu, N.
    Hogaboam, C. M.
    Jiang, D.
    Noble, P. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [39] Targeting of phosphatidylserine by monoclonal antibodies augments the activity of immune checkpoint inhibitor PD-1/PD-L1 therapy in murine breast tumors
    Gray, M.
    Gong, J.
    Nguyen, V.
    Hutchins, J.
    Freimark, B.
    CANCER RESEARCH, 2016, 76
  • [40] Isothiocyanates attenuate immune checkpoint blockage therapy in gastric cancer via induction of PD-L1 expression
    Zhang, Qi
    Cao, Wanshuang
    Yang, Chenying
    Hong, Lixia
    Geng, Shanshan
    Han, Hongyu
    Zhong, Caiyun
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2023, 112
12345